%0 Journal Article
%@ 1438-8871
%I JMIR Publications
%V 22
%N 7
%P e19781
%T QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study
%A Mazoteras-Pardo,Victoria
%A Becerro-De-Bengoa-Vallejo,Ricardo
%A Losa-Iglesias,Marta Elena
%A Martínez-Jiménez,Eva María
%A Calvo-Lobo,César
%A Romero-Morales,Carlos
%A López-López,Daniel
%A Palomo-López,Patricia
%+ Faculty of Health Sciences, Universidad Rey Juan Carlos, Avenida de Atenas S/N, Alcorcón, Spain, 34 91 488 8508, marta.losa@urjc.es
%K blood pressure
%K hypertension
%K type 2 diabetes
%K mobile applications
%K software validation
%D 2020
%7 24.7.2020
%9 Original Paper
%J J Med Internet Res
%G English
%X Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension. 
%M 32706672
%R 10.2196/19781
%U http://www.jmir.org/2020/7/e19781/
%U https://doi.org/10.2196/19781
%U http://www.ncbi.nlm.nih.gov/pubmed/32706672